The use of chloroquine diphosphate (aralen) and quinacrine (atabrine) hydrochloride in the prevention of polymorphorus light eruptions.
D035843:Biomedical Research; D002738:Chloroquine / Q000627:therapeutic use* / Q000031:analogs & derivatives; D008027:Light; D008180:Lupus Erythematosus, Systemic; D011796:Quinacrine / Q000627:therapeutic use*; D013472:Sunlight / Q000009:adverse effects*
C023676:chloroquine diphosphate; D002738:Chloroquine; D011796:Quinacrine
CHLOROQUINE/therapeutic use; LUPUS ERYTHEMATOSUS; QUINACRINE/therapeutic use; SUNLIGHT/injurious effects